RecruitingNot ApplicableNCT05927389

Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta

BONeMOVE : an Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta: an Interventional, Prospective, Regional, Bicentric Study.

Sponsor

University Hospital, Toulouse

Enrollment

30 participants

Start Date

Feb 26, 2024

Study Type

INTERVENTIONAL

Conditions

Osteogenesis Imperfecta

Summary

This research study aims to evaluate the effect of a 6-month adapted physical activity program (APA) on the endurance capacities (evaluated as the maximum oxygen consumption \[VO2 peak\]) of children and adolescents with Osteogenesis Imperfecta.

Eligibility

Min Age: 7 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Adapted Physical Activity program for people with osteogenesis imperfecta. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 7 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAdapted Physical Activity program

The Adaptated Physical Activity program consists of a Personalized Training Program adapted to each patient's condition and capacities

Locations(2)

CHU Montpellier Hôpital Arnaud de Villeneuve

Montpellier, France

CHU Toulouse

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05927389

Related Trials

Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

NCT073660864 locations

Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

NCT0597255165 locations

Effects of Bisphosphonates on OI-Related Hearing Loss

NCT041525511 location

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

NCT074127821 location

Prospective Observational Cohort Study of Cardiac Structure and Function in Children and Adults With Osteogenesis Imperfecta

NCT072872411 location